| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | 1 | 1 | — | — | 1 | — | 1 | 1 | — | 1 | — |
| Sell | — | — | — | — | — | — | — | — | — | 1 | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 2.28 |
—
—
—
—
—
—
—
—
—
|
| 2025 | 2.28 |
—
—
—
—
—
—
—
—
—
—
—
—
|
| 2024 | 2.28 |
—
—
—
—
—
—
—
—
—
—
—
—
|
| 2023 | 2.28 |
—
—
—
—
—
—
—
—
—
—
—
—
|
| 2022 | 2.28 |
—
—
—
—
—
—
—
—
—
—
—
—
|
| 2021 | 2.28 |
—
—
—
—
—
—
—
—
—
—
—
—
|
| 2020 | 2.28 |
—
—
—
—
—
—
—
—
—
—
—
—
|
| 2019 | 2.28 |
—
—
—
—
—
—
—
—
—
—
—
—
|
| 2018 | 2.28 |
—
—
—
—
—
—
—
—
—
—
—
—
|
| 2017 | 2.28 |
—
—
—
—
—
—
—
—
—
—
—
—
|
| 2016 | 2.19 |
—
—
—
—
—
—
—
—
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 20.29 | 9.41 | 14.39 | 40.44 |
| Receivables | 73.59 | 81.76 | 40.67 | 41.95 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 631.63 | 451.00 | 462.33 | 499.99 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | — | — | — | — |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 47.51 | 48.54 | 57.50 | 58.14 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 95.41 | 98.86 | — | — |
—
|
| ’25 | 49.03 | 60.24 | 69.29 | 84.29 |
262.85
|
| ’24 | 51.37 | 50.12 | 55.78 | 52.58 |
209.85
|
| ’23 | 49.50 | 48.25 | 49.30 | 50.20 |
197.24
|
| ’22 | 40.79 | 43.02 | 43.50 | 47.84 |
175.15
|
| ’21 | 40.28 | 38.13 | 37.47 | 39.44 |
155.32
|
| ’20 | 46.41 | 28.48 | 38.17 | 46.27 |
159.34
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 30.76 | 34.38 | — | — |
—
|
| ’25 | 29.57 | 30.03 | 38.44 | 37.94 |
135.98
|
| ’24 | 21.07 | 36.96 | 33.97 | 33.88 |
125.88
|
| ’23 | 18.04 | 28.50 | 32.40 | 25.56 |
104.49
|
| ’22 | 18.57 | 29.88 | 24.33 | 32.81 |
105.59
|
| ’21 | 21.26 | 27.39 | 20.94 | 21.60 |
91.18
|
| ’20 | 23.85 | 31.79 | 29.98 | 30.47 |
116.10
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (17.83) | (32.87) | — | — |
—
|
| ’25 | 28.25 | 28.86 | (233.91) | (49.08) |
(225.88)
|
| ’24 | 19.42 | 34.65 | 27.70 | 30.11 |
111.88
|
| ’23 | 15.43 | (15.89) | 30.58 | 20.93 |
51.05
|
| ’22 | 17.50 | (23.78) | 22.57 | 28.37 |
44.67
|
| ’21 | 20.22 | 26.38 | 18.14 | 20.14 |
84.89
|
| ’20 | 4.30 | 24.37 | 26.04 | 24.20 |
78.91
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.48 | 0.56 | — | — |
—
|
| ’25 | 0.45 | 0.32 | (0.44) | 2.11 |
2.52
|
| ’24 | 0.56 | 0.44 | 0.66 | 0.39 |
2.04
|
| ’23 | 0.80 | 0.15 | 0.54 | 0.67 |
2.16
|
| ’22 | 0.36 | 1.36 | 0.32 | 0.44 |
2.48
|
| ’21 | 0.35 | 0.46 | 0.28 | 0.32 |
1.41
|
| ’20 | 1.60 | 0.05 | 0.31 | 0.45 |
2.42
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 32.23 | 30.50 | 30.30 | 31.70 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 45.49 | 38.94 | 39.89 | 37.25 | — | — | — |
High Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 24 | 23 | 23 | 25 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.30 | 8.58 | 9.12 | 10.51 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 175.15 | 197.24 | 209.85 | 262.85 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 100.00% | 100.00% | 100.00% | 100.00% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 100.58 | 91.46 | 94.88 | 123.88 | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 57.43% | 46.37% | 45.21% | 47.13% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 100.58 | 91.46 | 94.88 | 123.88 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 39.51 | 39.39 | 38.24 | 40.19 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.39 | 4.78 | 4.80 | 5.69 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 2.49 | 2.16 | 2.07 | 2.54 | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.65 | 2.53 | 2.88 | 2.94 | ‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.53) | (1.29) | (0.32) | (7.83) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.12 | 1.24 | 2.56 | (4.89) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21.31 | 22.20 | 24.07 | 25.14 | ‡‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 39.89 | 41.27 | 43.74 | 46.23 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.30 | 14.94 | 16.77 | 13.92 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.14 | 6.75 | 7.20 | 6.05 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.68 | 1.45 | 1.44 | 1.37 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.74 | 11.42 | 10.65 | 9.38 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 49.97 | 44.11 | 19.98 | (10.92) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 105.59 | 104.49 | 125.88 | 135.98 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (60.92) | (53.44) | (13.99) | (361.86) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 44.67 | 51.05 | 111.88 | (225.88) | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 488.40 | 584.11 | 402.46 | 404.84 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 816.85 | 891.32 | 684.60 | 842.18 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 806.48 | 871.03 | 675.19 | 827.79 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 850.31 | 916.27 | 1,053.01 | 1,162.38 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.29% | 5.08% | 4.96% | 6.10% | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.74% | 3.15% | 3.34% | 3.68% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.47% | 10.09% | 9.18% | 10.59% | ‡‡‡‡‡ | — | — |
ROE
|
LTC Properties, Inc. is poised at a transformative inflection point in the senior housing and healthcare REIT sector, riding America’s aging “silver tsunami” with surging revenue, resilient post-COVID recovery, and insiders aggressively buying shares. Despite pandemic lows that slashed occupancy and profits, the company has rebounded strongly, boasting 14% CAGR in revenue per share to $4.80, explosive free cash flow growth to $2.54 per share, and a debt-light balance sheet with 99%+ rent collection rates—thanks to its efficient triple-net lease model.
Fundamentals shine with steady EPS around $2.07, robust EBT margins near 45%, and efficiency metrics like revenue per employee doubling to $9.1 million, all while pivoting to high-moat properties like memory care amid Alzheimer’s projections tripling by 2050. Insider purchases totaling $868,000 in 2025 signal hidden catalysts, aligning with blockbuster forecasts: revenue exploding 19% to $249 million in 2025, then 72% to $430 million in 2026, driven by demographic demand and stabilizing occupancies at 82%.
Trading at compelling valuations—PB 1.4x, EV/FCF 20x, with 10-15% upside to analyst highs—LTC offers multi-year growth potential as M&A and scale unlock value, outweighing rate risks in this battle-tested play on inevitable long-term care expansion.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.